Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.

Conference Paper

MASCC20-ABS-1534

Duke Authors

Cited Authors

  • Peters, KB; Kirkpatrick, J; Batinic-Haberle, I; Affronti, ML; Woodring, S; Iden, D; Lipp, ES; Healy, P; Herndon, JE; Boyd, K; Hahn, K; Spasojevic, I; Gad, S; Silberstein, D; Johnson, MO; Randazzo, D; Desjardins, A; Friedman, HS; Ashley, D; Crapo, J

Duke Contributors

Published Date

  • 2020

Published In

Published By

International Standard Serial Number (ISSN)

  • 0941-4355

Conference Name

  • 2020 MASCC/ISOO Annual Meeting

Conference Location

  • Seville, Spain

Conference Start Date

  • June 25, 2020

Conference End Date

  • June 27, 2020